Profile for Dicerna Pharmaceuticals, Inc. (DRNA)
« Back to company indexDRNA Chatter Timeline
Stock Ticker for DRNA
Most Active Tweeters for DRNA
| User | Tweets |
|---|---|
| @RNAiAnalyst | 9 |
| @WeekHerald | 8 |
| @AmericanBanking | 7 |
| @TickerReport | 7 |
| @ConsumerFeed | 6 |
Recent Tweets for DRNA
 |
@TranscriptDaily -$0.42 EPS Expected for Dicerna Pharmaceuticals $DRNA This Quarter https://t.co/0mVCKWj6dB May 25th 2018, 5:05pm |
 |
@dispatchtribune Analysts Anticipate Dicerna Pharmaceuticals $DRNA Will Post Quarterly Sales of $1.79 Million https://t.co/YlQwETg7TA May 25th 2018, 4:05pm |
 |
@ledgerzette Dicerna Pharmaceuticals $DRNA Expected to Post Earnings of -$0.42 Per Share https://t.co/mf8ro99SR4 May 25th 2018, 12:05pm |
 |
@TopTickrs RT @normanweekly: Godsey & Gibb Associates Has Trimmed Its Visa $V Position; Dicerna Pharmaceuticals $DRNA Shorts Raised By 26.17% - https:… May 25th 2018, 7:05am |
 |
@normanweekly Godsey & Gibb Associates Has Trimmed Its Visa $V Position; Dicerna Pharmaceuticals $DRNA Shorts Raised By 26.17% - https://t.co/T14i3OaDCz May 25th 2018, 7:05am |
 |
@ThisLincolnian Comparing Newron Pharmaceuticals $NWPHF & Dicerna Pharmaceuticals $DRNA https://t.co/YfhNO0lPhe May 24th 2018, 6:05am |
 |
@utahherald As Dicerna Pharmaceuticals $DRNA Stock Rose, Ra Capital Management Upped Position; Fundx Investment Group Has Raise… https://t.co/7lRaXcUty7 May 23rd 2018, 11:05am |
 |
@TickerReport Dicerna Pharmaceuticals $DRNA Expected to Announce Earnings of -$0.46 Per Share https://t.co/QsBoJliOJV May 23rd 2018, 5:05am |
 |
@WatchlistN Zacks: Brokerages Anticipate Dicerna Pharmaceuticals $DRNA Will Post Earnings of -$0.46 Per Share https://t.co/ds04LTtoQY May 23rd 2018, 5:05am |
 |
@WeekHerald Dicerna Pharmaceuticals $DRNA Receives Consensus Rating of “Buy” from Analysts https://t.co/cT1iVD43N7 May 22nd 2018, 11:05am |
|
@WeekHerald Dicerna Pharmaceuticals $DRNA Expected to Post Quarterly Sales of $1.79 Million https://t.co/8HaE6vl9xX May 22nd 2018, 6:05am |
 |
@AmericanBanking Dicerna Pharmaceuticals $DRNA Expected to Post Quarterly Sales of $1.79 Million https://t.co/fbyJHz5HaR #stocks May 22nd 2018, 2:05am |
|
@TickerReport Dicerna Pharmaceuticals $DRNA Expected to Post Quarterly Sales of $1.79 Million https://t.co/aaxn4o7Fex May 22nd 2018, 2:05am |
 |
@dailypoliticaln Zacks: Analysts Anticipate Dicerna Pharmaceuticals $DRNA Will Announce Quarterly Sales of $1.79 Million https://t.co/ZnUqmqPASx May 22nd 2018, 2:05am |
|
@AmericanBanking Newron Pharmaceuticals $NWPHF vs. Dicerna Pharmaceuticals $DRNA Critical Contrast https://t.co/Xz7I3frfeB #stocks May 21st 2018, 7:05am |
 |
@dakotafinancial Newron Pharmaceuticals $NWPHF vs. Dicerna Pharmaceuticals $DRNA Critical Contrast https://t.co/CCGdvQRuDT May 21st 2018, 7:05am |
 |
@TheMarketsDaily Critical Contrast: Newron Pharmaceuticals $NWPHF & Dicerna Pharmaceuticals $DRNA https://t.co/XdgWPMkIvI May 21st 2018, 7:05am |
|
@AmericanBanking Zacks: Analysts Anticipate Dicerna Pharmaceuticals $DRNA to Post -$0.46 Earnings Per Share https://t.co/x9M78w7sd3 #stocks May 20th 2018, 9:05pm |
|
@WeekHerald Zacks: Analysts Anticipate Dicerna Pharmaceuticals $DRNA to Post -$0.46 Earnings Per Share https://t.co/AlaFcOoRpn May 20th 2018, 9:05pm |
 |
@ConsumerFeed -$0.46 EPS Expected for Dicerna Pharmaceuticals $DRNA This Quarter https://t.co/t0L6irPX6o May 20th 2018, 9:05pm |
|
@ConsumerFeed Dicerna Pharmaceuticals $DRNA Receives $14.20 Average Price Target from Analysts https://t.co/KmfV80KJAt May 20th 2018, 11:05am |
|
@TranscriptDaily Q2 2018 EPS Estimates for Dicerna Pharmaceuticals Increased by Analyst $DRNA https://t.co/WXQ2RI4NjN May 20th 2018, 1:05am |
 |
@ZolmaxNews Dicerna Pharmaceuticals $DRNA Earns Hold Rating from HC Wainwright https://t.co/c5gB66sEjs May 19th 2018, 4:05pm |
|
@dailypoliticaln Dicerna Pharmaceuticals $DRNA Earns Hold Rating from HC Wainwright https://t.co/vLeb1bMUg4 May 19th 2018, 3:05pm |
|
@WeekHerald FY2018 Earnings Forecast for Dicerna Pharmaceuticals Issued By B. Riley $DRNA https://t.co/XjP7Ts2swm May 19th 2018, 6:05am |
|
@TickerReport FY2018 Earnings Forecast for Dicerna Pharmaceuticals Issued By B. Riley $DRNA https://t.co/x6ymYeDgrx May 19th 2018, 3:05am |
|
@TickerReport FY2018 Earnings Forecast for Dicerna Pharmaceuticals Issued By B. Riley $DRNA https://t.co/2XIb8BgU0D May 19th 2018, 3:05am |
|
@WatchlistN FY2018 Earnings Forecast for Dicerna Pharmaceuticals Issued By B. Riley $DRNA https://t.co/RhdSo7OkAB May 19th 2018, 2:05am |
|
@TickerReport FY2018 Earnings Forecast for Dicerna Pharmaceuticals Issued By B. Riley $DRNA https://t.co/ATO1R5fdyv May 19th 2018, 2:05am |
|
@ConsumerFeed Dicerna Pharmaceuticals’ $DRNA “Hold” Rating Reiterated at HC Wainwright https://t.co/PChKQLgvO2 May 18th 2018, 12:05pm |
 |
@Shas_el $DRNA up to $250.0 Mil - New Shelf - No Shares Disclosed • May 18th 2018, 12:05pm |
|
@ConsumerFeed SunTrust Banks Brokers Raise Earnings Estimates for Dicerna Pharmaceuticals $DRNA https://t.co/EsbjdFKFQZ May 18th 2018, 10:05am |
|
@WeekHerald SunTrust Banks Brokers Raise Earnings Estimates for Dicerna Pharmaceuticals $DRNA https://t.co/jODVxYhhJu May 18th 2018, 9:05am |
 |
@Hypocrites_Oath RT @OpenOutcrier: $DRNA (+0.3% pre) Dicerna gets FDA Orphan Drug Designation for Treatment of primary hyperoxaluria - FDA https://t.co/0c7… May 18th 2018, 8:05am |
 |
@OpenOutcrier $DRNA (+0.3% pre) Dicerna gets FDA Orphan Drug Designation for Treatment of primary hyperoxaluria - FDA https://t.co/0c7G7fUF7G May 18th 2018, 8:05am |
|
@AmericanBanking Brokers Issue Forecasts for Dicerna Pharmaceuticals’ Q2 2018 Earnings $DRNA https://t.co/4SS5jZxVGQ #stocks May 18th 2018, 7:05am |
|
@dakotafinancial Brokers Issue Forecasts for Dicerna Pharmaceuticals’ Q2 2018 Earnings $DRNA https://t.co/fth9Wrurfe May 18th 2018, 7:05am |
|
@ledgerzette B. Riley Comments on Dicerna Pharmaceuticals’ FY2018 Earnings $DRNA https://t.co/Y9bxLmoXS3 May 18th 2018, 6:05am |
|
@ZolmaxNews Dicerna Pharmaceuticals $DRNA Shares Down 0.7% https://t.co/KKDTyxvRif May 18th 2018, 5:05am |
|
@TheMarketsDaily B. Riley Comments on Dicerna Pharmaceuticals’ FY2018 Earnings $DRNA https://t.co/thN0Bx3ZwJ May 18th 2018, 2:05am |
|
@dakotafinancial B. Riley Comments on Dicerna Pharmaceuticals’ FY2018 Earnings $DRNA https://t.co/Z7xbPuAOqQ May 18th 2018, 2:05am |
|
@TheMarketsDaily Dicerna Pharmaceuticals $DRNA Given Consensus Recommendation of “Buy” by Brokerages https://t.co/VazQ3kl8tI May 17th 2018, 5:05pm |
|
@ThisLincolnian Dicerna Pharmaceuticals $DRNA Given Consensus Recommendation of “Buy” by Brokerages https://t.co/5Yky9GCaHt May 17th 2018, 5:05pm |
 |
@kuritzmike RT @odibro: $DRNA $250M mixed shelf filed https://t.co/5WsI5Kn8uT May 17th 2018, 5:05pm |
 |
@NewsQuantified $DRNA granted orphan status for hyperoxaluria treatment, stock boosts +2.68%, #Dicerna https://t.co/60In2x8YIP May 17th 2018, 5:05pm |
 |
@vijay9933 Hahha sold to you retails ! Does anybody care for ODD $DRNA . 250 m shelf and 25 million shares unloading from inst… https://t.co/rYUYBwbvDV May 17th 2018, 4:05pm |
 |
@LanderJesse RT @BioRunUp: $DRNA gets FDA Orphan Drug Designation for Treatment of primary hyperoxaluria Just hit FDA database 1 minute ago https://t.… May 17th 2018, 4:05pm |
 |
@BioRunUp $DRNA gets FDA Orphan Drug Designation for Treatment of primary hyperoxaluria Just hit FDA database 1 minute ago https://t.co/zqGFbqLNCW May 17th 2018, 4:05pm |
|
@TickerReport Dicerna Pharmaceuticals $DRNA Receives “Hold” Rating from HC Wainwright https://t.co/1lNyUCc4x7 May 17th 2018, 1:05pm |
|
@dispatchtribune HC Wainwright Reiterates “Hold” Rating for Dicerna Pharmaceuticals $DRNA https://t.co/qvLTyNOks8 May 17th 2018, 1:05pm |
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.